Example collocations logo

Pharmaceutical in sentence

484 examples of Pharmaceutical in a sentence

The vaccine field was dominated by a handful of multinational pharmaceutical companies in rich countries, and the entire sector suffered from a lack of competition.
Private actors from foundations to pharmaceutical corporations to NGOs are actively experimenting with alternative ways to tackle transnational health challenges.
To be sure, such an “open source” approach is not standard practice in pharmaceutical research and development.
With business interests dictating global pharmaceutical priorities, developing countries consistently lose out – with devastating consequences.
And, given the high cost of R&D, pharmaceutical companies are naturally concerned about competitors reverse-engineering their drugs.
Lasting, collaborative relationships among pharmaceutical companies, governments, nonprofit organizations, and community leaders are needed to help disadvantaged populations overcome their health-care challenges.
The world has known about the deadly nature of the Ebola virus since 1976; but, because its victims were poor, pharmaceutical companies had no incentive to develop a vaccine.
Indeed, pharmaceutical companies could expect to earn more from a cure for male baldness.
That question will soon need to be answered, because both the pharmaceutical giant GlaxoSmithKline (in conjunction with the US National Institute of Allergy and Infectious Diseases) and the Public Health Agency of Canada have candidate vaccines in development.
The medicalization of depression has proven to be even more profitable for pharmaceutical companies, whose sales of anti-depressant medications have soared.
Many life-saving drugs, notably those used to fight AIDS, are produced under patents mainly by US and European pharmaceutical companies.
In rich countries, patent protection should continue so that the pharmaceutical industry keeps innovating.
And here, Obama appears determined to undermine his own signature reform, owing to pressure from the powerful US pharmaceutical lobby.
Lowering health-care costs thus requires greater competition in the pharmaceutical industry – and that means allowing the manufacture and distribution of generic drugs.
Major multinational pharmaceutical companies have long been working to block competition from generics.
In the 1970s, India abolished pharmaceutical patents, creating an advanced and efficient generics industry capable of providing affordable medicines to people throughout the developing world.
But, in the view of America’s pharmaceutical industry, TRIPS did not go far enough.
The US participants in the group will be led by the Office of the US Trade Representative, which serves the pharmaceutical companies’ interests, rather than, say, the National Academy of Sciences, the National Science Foundation, or the National Institutes of Health.
In fact, the threat of competition from Indian generics is partly responsible for major pharmaceutical companies’ decision to make some of their drugs available to the world’s poor at low prices.
Of course, if America’s strong patent regime were, as its proponents claim, the best way to foster innovation in the pharmaceutical industry, the Obama administration’s policy toward India could perhaps be justified.
Only the major pharmaceutical companies, working in conjunction with basic and applied research centers around the world, can mobilize the necessary funding.
Of course, in the end, success in malaria control, or AIDs control, will require a partnership between the WHO, the private pharmaceutical companies, academic research establishments, and the world's governments.
The impact of marketing efforts by pharmaceutical companies and publicity probably plays a role in the emerging tendency to over-diagnose bipolar disorder.
This bias is reinforced by the marketing message of pharmaceutical companies to physicians, which has emphasized research on delayed diagnosis and under-recognition of bipolar disorder, possibly sensitizing clinicians accordingly.
It extends to mainstream hits like The Constant Gardener , in which the idealistic protagonists do battle with a malicious global pharmaceutical company that is bent on exploiting Africa’s misery to test experimental drugs.
Capital-intensive companies, especially pharmaceutical firms, began leaving.
This is as silly as contending that antiretroviral drugs won’t work in the region, and that treating HIV is all a giant plot on the part of big pharmaceutical companies.
Blood can serve as the basis for immortalized cell lines in biological studies and in developing pharmaceutical products.
His physician patented certain chemicals in Moore's blood without his knowledge or consent, set up contracts, and sold the rights to a Swiss pharmaceutical company to produce drugs from the "Mo" cell line.
Another innovation is a vaccine called AGS-v, developed by the London-based pharmaceutical company SEEK to provide broad protection against a range of mosquito-borne diseases.
BackNext